A citation-based method for searching scientific literature

Paula Kopschina Feltes, Janine Doorduin, Hans C Klein, Luis Eduardo Juárez-Orozco, Rudi Ajo Dierckx, Cristina M Moriguchi-Jeckel, Erik Fj de Vries. J Psychopharmacol 2017
Times Cited: 86







List of co-cited articles
854 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
31

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
25


From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
17

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
833
15


Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
406
15

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
528
13

The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
598
13

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
13

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
432
12

Depression as a microglial disease.
Raz Yirmiya, Neta Rimmerman, Ronen Reshef. Trends Neurosci 2015
330
12

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.
Ole Kohler, Jesper Krogh, Ole Mors, Michael Eriksen Benros. Curr Neuropharmacol 2016
155
11



Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
426
10

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
457
10

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.
Jennifer L Warner-Schmidt, Kimberly E Vanover, Emily Y Chen, John J Marshall, Paul Greengard. Proc Natl Acad Sci U S A 2011
190
10

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
J C O'Connor, M A Lawson, C André, M Moreau, J Lestage, N Castanon, K W Kelley, R Dantzer. Mol Psychiatry 2009
730
10

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Elaine Setiawan, Alan A Wilson, Romina Mizrahi, Pablo M Rusjan, Laura Miler, Grazyna Rajkowska, Ivonne Suridjan, James L Kennedy, P Vivien Rekkas, Sylvain Houle,[...]. JAMA Psychiatry 2015
393
10

Inflamed moods: a review of the interactions between inflammation and mood disorders.
Joshua D Rosenblat, Danielle S Cha, Rodrigo B Mansur, Roger S McIntyre. Prog Neuropsychopharmacol Biol Psychiatry 2014
299
9


Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
178
9

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi, Abbas Ali Nasehi, Aboulfazl Ghoreishi, Bahman Salehi, Soodeh Mohebbi-Rasa, Maedeh Raznahan, Abbas Kamalipour. Depress Anxiety 2009
233
9


Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.
P Zheng, B Zeng, C Zhou, M Liu, Z Fang, X Xu, L Zeng, J Chen, S Fan, X Du,[...]. Mol Psychiatry 2016
629
8

The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.
Johan Dahl, Heidi Ormstad, Hans Christian D Aass, Ulrik Fredrik Malt, Lil Träskman Bendz, Leiv Sandvik, Lena Brundin, Ole A Andreassen. Psychoneuroendocrinology 2014
181
8

The Role of Depressive Subtypes within the Neuroinflammation Hypothesis of Major Depressive Disorder.
Marie Woelfer, Vanessa Kasties, Sascha Kahlfuss, Martin Walter. Neuroscience 2019
45
15

So depression is an inflammatory disease, but where does the inflammation come from?
Michael Berk, Lana J Williams, Felice N Jacka, Adrienne O'Neil, Julie A Pasco, Steven Moylan, Nicholas B Allen, Amanda L Stuart, Amie C Hayley, Michelle L Byrne,[...]. BMC Med 2013
565
8

Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
496
8

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
506
8

Integrating neuroimmune systems in the neurobiology of depression.
Eric S Wohleb, Tina Franklin, Masaaki Iwata, Ronald S Duman. Nat Rev Neurosci 2016
240
8

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
6

NSAIDs are associated with lower depression scores in patients with osteoarthritis.
Rupa L Iyengar, Sumeet Gandhi, Ashish Aneja, Kevin Thorpe, Louai Razzouk, Jeffery Greenberg, Serge Mosovich, Michael E Farkouh. Am J Med 2013
49
12


Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
270
6

Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis.
T Kreisel, M G Frank, T Licht, R Reshef, O Ben-Menachem-Zidon, M V Baratta, S F Maier, R Yirmiya. Mol Psychiatry 2014
321
6

β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat.
Eric S Wohleb, Mark L Hanke, Angela W Corona, Nicole D Powell, La'Tonia M Stiner, Michael T Bailey, Randy J Nelson, Jonathan P Godbout, John F Sheridan. J Neurosci 2011
393
6

A review of the relationship between proinflammatory cytokines and major depressive disorder.
Juan Joseph Young, Davide Bruno, Nunzio Pomara. J Affect Disord 2014
202
6


Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system.
L A Carvalho, J P Torre, A S Papadopoulos, L Poon, M F Juruena, K Markopoulou, A J Cleare, C M Pariante. J Affect Disord 2013
97
6

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.
Sinead M O'Brien, Paul Scully, Peter Fitzgerald, Lucinda V Scott, Timothy G Dinan. J Psychiatr Res 2007
259
6


Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
Muhammad I Husain, Imran B Chaudhry, Nusrat Husain, Ameer B Khoso, Raza R Rahman, Munir M Hamirani, John Hodsoll, Inti Qurashi, John Fw Deakin, Allan H Young. J Psychopharmacol 2017
60
10

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, Michael Maes, Marco Solmi, Nicola Veronese, Nayanna Q de Andrade, Gerwyn Morris, Brisa S Fernandes, André R Brunoni,[...]. Mol Neurobiol 2018
162
6

Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials.
O Köhler-Forsberg, C N Lydholm, C Hjorthøj, M Nordentoft, O Mors, M E Benros. Acta Psychiatr Scand 2019
82
7

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.
Michael Maes, Michael Berk, Lisa Goehler, Cai Song, George Anderson, Piotr Gałecki, Brian Leonard. BMC Med 2012
296
5

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Stephen Tyring, Alice Gottlieb, Kim Papp, Ken Gordon, Craig Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik,[...]. Lancet 2006
719
5

Cytokine-associated emotional and cognitive disturbances in humans.
A Reichenberg, R Yirmiya, A Schuld, T Kraus, M Haack, A Morag, T Pollmächer. Arch Gen Psychiatry 2001
847
5

Altered fecal microbiota composition in patients with major depressive disorder.
Haiyin Jiang, Zongxin Ling, Yonghua Zhang, Hongjin Mao, Zhanping Ma, Yan Yin, Weihong Wang, Wenxin Tang, Zhonglin Tan, Jianfei Shi,[...]. Brain Behav Immun 2015
720
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.